Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scavenger receptors are a superfamily of "cell surface receptors" that bind a wide variety of ligands—including modified lipoproteins, apoptotic cells, and microbial components—and promote the removal of non-self or altered-self targets[4][1][3]. They function as pattern recognition receptors (PRRs) involved in the recognition, endocytosis, phagocytosis, adhesion, and signaling, leading to elimination of harmful substances and linking innate to adaptive immunity[6][3][4]. Scavenger receptors are structurally heterogeneous and are grouped into several classes (at least 10 in mammals: A-L) based on protein structure and ligand specificity[2][4][3]. Major members include class A (SR-A1/MSR1, SCARA family), class B (SR-BI, CD36), class D (SR-D1/CD68), and others, with diverse roles in "innate immunity, atherosclerosis, infection, neurodegeneration, and inflammation"[1][2][8]. They are predominantly expressed on myeloid cells (macrophages, monocytes, dendritic cells), but also found on endothelial cells and other immune and non-immune cells[3][8]. Owing to broad ligand specificity, scavenger receptors can cooperate with Toll-like receptors (TLRs) in cellular immune responses and may serve as therapeutic targets or disease biomarkers in cardiovascular, infectious, metabolic, and inflammatory disorders[2][6][7].
Inhibition or modulation of ligand binding/uptake (e.g. oxidized LDL, pathogens, lipids); Suppression of phagocytosis; Attenuation of inflammatory signaling; Blockade of specific SR classes (A, B, etc.) in disease models
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptor (null).